Received Jul 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 1 | T5D73 | IM / LA |
Engerix-B (Age 20+) is approved for 20 years and older, but the patient was18 years old. Patient should have been given Engerix-B (Age 0-19) instead. The error was discovered as the patient was seeking to get the second dose of Engerix B series. Patient did not have any signs of adverse reactions in the past month.
unknown
unknown
unknown
no known drug allergy
NONE